Macrophage peroxisome proliferator activated receptor gamma as a therapeutic target to combat Type 2 diabetes - PubMed (original) (raw)
Review
Macrophage peroxisome proliferator activated receptor gamma as a therapeutic target to combat Type 2 diabetes
Gabriel Pascual et al. Expert Opin Ther Targets. 2007 Nov.
Abstract
The peroxisome proliferator activated receptor gamma is a member of the nuclear receptor superfamily of ligand-dependent transcription factors and is the molecular target of antidiabetic thiazolidinediones that exert insulin sensitizing effects in adipose tissue, skeletal muscle and the liver. In addition to the well described effects of peroxisome proliferator activated receptor gamma in insulin target tissues, it is now apparent that its expression in macrophages is critical in the regulation of macrophage phenotype, whole body glucose metabolism and in mediating, in part, the antidiabetic actions of thiazolidinediones. As macrophages are major contributors to tissue inflammation and are resident in tissues responsible for maintaining glucose homeostasis, the therapeutic potential of these cells in the treatment of Type 2 diabetes is of significant clinical interest.
Similar articles
- Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolism.
Fogo AB. Fogo AB. Curr Opin Nephrol Hypertens. 2008 May;17(3):282-5. doi: 10.1097/MNH.0b013e3282f9b1c0. Curr Opin Nephrol Hypertens. 2008. PMID: 18408479 Review. - Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones.
Hevener AL, Olefsky JM, Reichart D, Nguyen MT, Bandyopadyhay G, Leung HY, Watt MJ, Benner C, Febbraio MA, Nguyen AK, Folian B, Subramaniam S, Gonzalez FJ, Glass CK, Ricote M. Hevener AL, et al. J Clin Invest. 2007 Jun;117(6):1658-69. doi: 10.1172/JCI31561. Epub 2007 May 24. J Clin Invest. 2007. PMID: 17525798 Free PMC article. - Advances on PPARγ Research in the Emerging Era of Precision Medicine.
Lu P, Zhao Z. Lu P, et al. Curr Drug Targets. 2018;19(6):663-673. doi: 10.2174/1389450118666170622091333. Curr Drug Targets. 2018. PMID: 28641522 Review. - Anti-inflammatory and antidiabetic roles of PPARgamma.
Pascual G, Sullivan AL, Ogawa S, Gamliel A, Perissi V, Rosenfeld MG, Glass CK. Pascual G, et al. Novartis Found Symp. 2007;286:183-96; discussion 196-203. doi: 10.1002/9780470985571.ch16. Novartis Found Symp. 2007. PMID: 18269183 - The effect of peroxisome proliferator-activated receptor-γ ligands on in vitro and in vivo models of COPD.
Lea S, Plumb J, Metcalfe H, Spicer D, Woodman P, Fox JC, Singh D. Lea S, et al. Eur Respir J. 2014 Feb;43(2):409-20. doi: 10.1183/09031936.00187812. Epub 2013 Jun 21. Eur Respir J. 2014. PMID: 23794466
Cited by
- Microglial phenotypes in Parkinson's disease and animal models of the disease.
Joers V, Tansey MG, Mulas G, Carta AR. Joers V, et al. Prog Neurobiol. 2017 Aug;155:57-75. doi: 10.1016/j.pneurobio.2016.04.006. Epub 2016 Apr 20. Prog Neurobiol. 2017. PMID: 27107797 Free PMC article. Review. - Nuclear Mechanisms of Insulin Resistance.
Kang S, Tsai LT, Rosen ED. Kang S, et al. Trends Cell Biol. 2016 May;26(5):341-351. doi: 10.1016/j.tcb.2016.01.002. Epub 2016 Jan 25. Trends Cell Biol. 2016. PMID: 26822036 Free PMC article. Review. - Long-term effects of placental growth on overweight and body composition.
Eriksson JG, Gelow J, Thornburg KL, Osmond C, Laakso M, Uusitupa M, Lindi V, Kajantie E, Barker DJ. Eriksson JG, et al. Int J Pediatr. 2012;2012:324185. doi: 10.1155/2012/324185. Epub 2012 Apr 18. Int J Pediatr. 2012. PMID: 22570665 Free PMC article. - Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine.
Brown BN, Ratner BD, Goodman SB, Amar S, Badylak SF. Brown BN, et al. Biomaterials. 2012 May;33(15):3792-802. doi: 10.1016/j.biomaterials.2012.02.034. Epub 2012 Mar 3. Biomaterials. 2012. PMID: 22386919 Free PMC article. Review. - Correlation of Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) and Retinoid X Receptor-alpha (RXR-alpha) expression with clinical risk factors in patients with advanced carotid atherosclerosis.
Giaginis C, Klonaris C, Katsargyris A, Kouraklis G, Spiliopoulou C, Theocharis S. Giaginis C, et al. Med Sci Monit. 2011 Jul;17(7):CR381-91. doi: 10.12659/msm.881849. Med Sci Monit. 2011. PMID: 21709632 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials